Search research articles
Contact Us
Filters
Showing results (821-830 of 945) with videos related to
Page
of 95
Sort By:
Molecular Metabolism
|
October 20, 2018
Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates
Stephanie R Wesolowski, Christopher M Mulligan, Rachel C Janssen, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 9, 2022
Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis
Anthony T Ginnetti, Daniel V Paone, Kausik K Nanda, et al.
NPJ Breast Cancer
|
November 15, 2024
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer
Lauren D Otto-Dobos, Lindsay D Strehle, Brett R Loman, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Estrogen Signaling During Abrupt Involution Leads to Long-Term Metabolic Dysfunction Similar to Estrogen Receptor Negative Breast Cancer
Kate Ormiston, Neelam Shinde, Gautam Sarathy, et al.
Medical Microbiology and Immunology
|
June 17, 2009
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Janusz Wesolowski, Vanina Alzogaray, Jan Reyelt, et al.
Frontiers in Endocrinology
|
May 16, 2020
TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature
Hinda Boutrid, Mahmoud Kassem, Gary Tozbikian, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Estrogen Signaling During Abrupt Involution and Long-Term Metabolic Signature Similar to Estrogen Receptor-Negative Breast Cancer
Kate Ormiston, Neelam Shinde, Gautam Sarathy, et al.
Breast Cancer Research : BCR
|
March 8, 2014
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
Maryam B Lustberg, Priya Balasubramanian, Brandon Miller, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 27, 2011
Multiparameter exploration of piperazine derivatives as δ-opioid receptor agonists for CNS indications
John P McCauley, Cathy L Dantzman, Megan M King, et al.
Cancer Medicine
|
April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
Page
of 95
Search research articles
Search
Showing results (821-830 of 945) with videos related to
Sort By:
Page
of 95
Molecular Metabolism
|
October 20, 2018
Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates
Stephanie R Wesolowski, Christopher M Mulligan, Rachel C Janssen, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 9, 2022
Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis
Anthony T Ginnetti, Daniel V Paone, Kausik K Nanda, et al.
NPJ Breast Cancer
|
November 15, 2024
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer
Lauren D Otto-Dobos, Lindsay D Strehle, Brett R Loman, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Estrogen Signaling During Abrupt Involution Leads to Long-Term Metabolic Dysfunction Similar to Estrogen Receptor Negative Breast Cancer
Kate Ormiston, Neelam Shinde, Gautam Sarathy, et al.
Medical Microbiology and Immunology
|
June 17, 2009
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Janusz Wesolowski, Vanina Alzogaray, Jan Reyelt, et al.
Frontiers in Endocrinology
|
May 16, 2020
TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature
Hinda Boutrid, Mahmoud Kassem, Gary Tozbikian, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Estrogen Signaling During Abrupt Involution and Long-Term Metabolic Signature Similar to Estrogen Receptor-Negative Breast Cancer
Kate Ormiston, Neelam Shinde, Gautam Sarathy, et al.
Breast Cancer Research : BCR
|
March 8, 2014
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
Maryam B Lustberg, Priya Balasubramanian, Brandon Miller, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 27, 2011
Multiparameter exploration of piperazine derivatives as δ-opioid receptor agonists for CNS indications
John P McCauley, Cathy L Dantzman, Megan M King, et al.
Cancer Medicine
|
April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
Page
of 95